 Activation of CB1 and CB2 receptors in animals has shown a strong anti-inflammatory effect.Cannabinoids and/or modulation of the endocannabinoid system is a novel therapeutic means for the treatment of numerous GI disorders, including inflammatory bowel diseases like Crohn's disease.A few small trials have looked at medical cannabis but further evidence is required to determine its usefulness.